| UniProt ID | MP2K5_HUMAN | |
|---|---|---|
| UniProt AC | Q13163 | |
| Protein Name | Dual specificity mitogen-activated protein kinase kinase 5 | |
| Gene Name | MAP2K5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 448 | |
| Subcellular Localization | ||
| Protein Description | Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis.. | |
| Protein Sequence | MLWLALGPFPAMENQVLVIRIKIPNSGAVDWTVHSGPQLLFRDVLDVIGQVLPEATTTAFEYEDEDGDRITVRSDEEMKAMLSYYYSTVMEQQVNGQLIEPLQIFPRACKPPGERNIHGLKVNTRAGPSQHSSPAVSDSLPSNSLKKSSAELKKILANGQMNEQDIRYRDTLGHGNGGTVYKAYHVPSGKILAVKVILLDITLELQKQIMSELEILYKCDSSYIIGFYGAFFVENRISICTEFMDGGSLDVYRKMPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDSPVLPVGEFSEPFVHFITQCMRKQPKERPAPEELMGHPFIVQFNDGNAAVVSMWVCRALEERRSQQGPP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 71 | Phosphorylation | DEDGDRITVRSDEEM CCCCCEEEECCHHHH | 15.68 | - | |
| 121 | Ubiquitination | ERNIHGLKVNTRAGP CCCCCCEEEECCCCC | 37.72 | - | |
| 125 | Methylation | HGLKVNTRAGPSQHS CCEEEECCCCCCCCC | 32.13 | 115483133 | |
| 129 | Phosphorylation | VNTRAGPSQHSSPAV EECCCCCCCCCCCCC | 39.34 | 25159151 | |
| 132 | Phosphorylation | RAGPSQHSSPAVSDS CCCCCCCCCCCCCCC | 30.31 | 21815630 | |
| 133 | Phosphorylation | AGPSQHSSPAVSDSL CCCCCCCCCCCCCCC | 18.11 | 25159151 | |
| 137 | Phosphorylation | QHSSPAVSDSLPSNS CCCCCCCCCCCCCCC | 24.48 | 29396449 | |
| 142 | Phosphorylation | AVSDSLPSNSLKKSS CCCCCCCCCCCCCCH | 44.32 | 18691976 | |
| 144 | Phosphorylation | SDSLPSNSLKKSSAE CCCCCCCCCCCCHHH | 46.00 | 25627689 | |
| 146 | Ubiquitination | SLPSNSLKKSSAELK CCCCCCCCCCHHHHH | 50.89 | - | |
| 148 | Phosphorylation | PSNSLKKSSAELKKI CCCCCCCCHHHHHHH | 32.94 | 18691976 | |
| 149 | Phosphorylation | SNSLKKSSAELKKIL CCCCCCCHHHHHHHH | 34.34 | 22817900 | |
| 154 | Ubiquitination | KSSAELKKILANGQM CCHHHHHHHHHCCCC | 56.42 | - | |
| 202 | Phosphorylation | KVILLDITLELQKQI EEHHHHHHHHHHHHH | 17.53 | 26074081 | |
| 211 | Phosphorylation | ELQKQIMSELEILYK HHHHHHHHHHHHHHH | 40.43 | 26074081 | |
| 217 | Phosphorylation | MSELEILYKCDSSYI HHHHHHHHHCCCCCE | 18.41 | 26074081 | |
| 298 | Ubiquitination | VNTRGQVKLCDFGVS ECCCCCEEECCCCCC | 35.19 | - | |
| 305 | Phosphorylation | KLCDFGVSTQLVNSI EECCCCCCHHHHHHH | 15.71 | 28102081 | |
| 306 | Phosphorylation | LCDFGVSTQLVNSIA ECCCCCCHHHHHHHH | 24.42 | 22210691 | |
| 311 | Phosphorylation | VSTQLVNSIAKTYVG CCHHHHHHHHHHCCC | 19.22 | 25159151 | |
| 315 | Phosphorylation | LVNSIAKTYVGTNAY HHHHHHHHCCCCCCE | 17.89 | 25159151 | |
| 316 | Phosphorylation | VNSIAKTYVGTNAYM HHHHHHHCCCCCCEE | 9.00 | 19060867 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 129 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
| 137 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
| 142 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
| 149 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MP2K5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MP2K5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| M3K2_HUMAN | MAP3K2 | physical | 11073940 | |
| M3K3_HUMAN | MAP3K3 | physical | 11073940 | |
| KPCZ_HUMAN | PRKCZ | physical | 11158308 | |
| MK07_HUMAN | MAPK7 | physical | 7759517 | |
| MP2K5_HUMAN | MAP2K5 | physical | 7759517 | |
| M3K3_MOUSE | Map3k3 | physical | 10593883 | |
| 1433Z_HUMAN | YWHAZ | physical | 20936779 | |
| MRCKB_HUMAN | CDC42BPB | physical | 20936779 | |
| ENOA_HUMAN | ENO1 | physical | 15805119 | |
| SQSTM_HUMAN | SQSTM1 | physical | 19903815 | |
| M3K2_HUMAN | MAP3K2 | physical | 19903815 | |
| ASGL1_HUMAN | ASRGL1 | physical | 21900206 | |
| KPCI_HUMAN | PRKCI | physical | 12813044 | |
| SQSTM_HUMAN | SQSTM1 | physical | 12813044 | |
| M3K3_HUMAN | MAP3K3 | physical | 12813044 | |
| PAR6A_HUMAN | PARD6A | physical | 12813044 | |
| XRCC6_HUMAN | XRCC6 | physical | 21988832 | |
| RL28_HUMAN | RPL28 | physical | 21988832 | |
| M3K2_HUMAN | MAP3K2 | physical | 21988832 | |
| M3K2_HUMAN | MAP3K2 | physical | 24975362 | |
| MK07_HUMAN | MAPK7 | physical | 24975362 | |
| MK07_HUMAN | MAPK7 | physical | 28514442 | |
| M3K2_HUMAN | MAP3K2 | physical | 28514442 | |
| M3K3_HUMAN | MAP3K3 | physical | 28514442 | |
| TRAF7_HUMAN | TRAF7 | physical | 28514442 | |
| CJ088_HUMAN | C10orf88 | physical | 28514442 | |
| CDC37_HUMAN | CDC37 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-137; SER-148; SER-149;SER-311; THR-315 AND TYR-316, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
| "Components of a new human protein kinase signal transductionpathway."; Zhou G., Bao Z.Q., Dixon J.E.; J. Biol. Chem. 270:12665-12669(1995). Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, INTERACTION WITHERK5 AND MAPK7, MUTAGENESIS OF LYS-195; SER-311 AND THR-315, ANDPHOSPHORYLATION AT SER-311 AND THR-315. | |